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Lack of scientific reproducibility is a growing concern and weak experimental practices
may contribute to irreproducibility. Here, we describe an optimized and versatile
protocol for stereotaxic intrahippocampal administration of Kainic Acid (KA) in mice
with a C57Bl6 background. In this protocol, KA administration is combined with
in vivo recording of neuronal activity with wired and wireless setups. Following our
protocol, KA administration results in a robust dose-dependent induction of low-level
epileptiform activity or Status Epilepticus (SE) and induces previously characterized
hallmarks of seizure-associated pathology. The procedure consists of three main steps:
Craniotomy, stereotaxic administration of KA, and placement of recording electrodes
in intrahippocampal, and subdural locations. This protocol offers extended possibilities
compared to the systemic administration of KA, as it allows the researcher to accurately
regulate the local dose of KA and resulting seizure activity, and permits the use and
study of convulsive and non-convulsive KA doses, resulting in higher reproducibility
and lower inter-individual variability and mortality rates. Caution should be taken when
translating this procedure to different strains of mice as inter-strain sensitivity to KA has
been described before. The procedure can be performed in∼1 h by a trained researcher,
while intrahippocampal administration of KA without placing recording electrodes can be
done in 25 min, and can be easily adapted to the titrated intrahippocampal administration
of other drugs.
Keywords: kainic acid, adult hippocampal neurogenesis, EEG, intrahippocampal administration, epilepsy,
temporal lobe
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INTRODUCTION
Many available animal models of Mesial Temporal lobe epilepsy
(mTLE), and in particular systemic KA administration, are
induced by acute treatments that often are associated with
high mortality and experimental variability rates (Hellier et al.,
1998; McLin and Steward, 2006; Kienzler-Norwood et al., 2017).
Modeling mTLE using experimental animals comprises, in
general, three well-defined stages: First, an initiating insult to
the brain, such as febrile seizures, head trauma, stroke, or strong
seizures leading to status epilepticus (SE). This initial insult
triggers a cascade of events resulting in a second, latent period,
during which molecular and structural changes take place,
commonly known as epileptogenesis. Finally, a third period
is characterized by the occurrence of spontaneous seizures,
resulting in chronic epilepsy (Raedt et al., 2009).
Several protocols are extensively used in preclinical research
to characterize epilepsy development, such as brain infarction,
traumatic brain damage, febrile seizures, electrical kindling, or
administration of chemoconvulsants such as the cholinomimetic
pilocarpine and the systemic or intrahippocampal administration
of the glutamate agonist kainic acid (KA) (Parent et al., 1997;
Hellier et al., 1998; Bouilleret et al., 1999; Hartings et al.,
2003; Kharatishvili et al., 2007; Dubé et al., 2010; Morales
et al., 2014). Each model has been developed and characterized
to have their own distinctive properties, including working
mechanism and/or pharmacokinetics, and each one of them may
model different aspects of epilepsy, providing clear advantageous
alternatives. On the other hand it is, in some cases, hard to
compare and combine data across models. Furthermore, several
of the above-mentioned models induce varying mortality rates
and are accompanied by severe animal welfare issues (Curia
et al., 2008; Lévesque and Avoli, 2013; Lidster et al., 2016).
Therefore, preclinical epilepsy research would benefit from more
detailed and standardized protocols, with lower mortality rates
and improved animal welfare, which could increase intra- and
inter-laboratory reproducibility (Lidster et al., 2016; Kienzler-
Norwood et al., 2017).
Here, we describe a detailed protocol for the intrahippocampal
administration of KA in mice, a well-characterized preclinical
epilepsy model that mimics major aspects of mTLE, in which
seizures originate in the hippocampus and/or related limbic
areas and which was first described by Bouilleret et al. (1999).
We have adapted the protocol to optimize the delivery of
KA to the dentate gyrus (DG), where local delivery of KA
induces the expression of several parameters associated with
seizure pathology, such as occurrence of spontaneous recurrent
seizures, gliosis, granule cell dispersion, and strong alterations
in resident neural stem cells, e.g., strong changes in gene
expression, neural stem cell activation, and subsequent depletion
of the hippocampal neural stem cell pool (Schouten et al.,
2015; Sierra et al., 2015). Experiments using this protocol in
combination with KA doses high enough to induce mTLE
have demonstrated the generation of spontaneous seizures and
interictal discharges that started 6 h after KA injection and
persisted for up to 50 days (Sierra et al., 2015). Therefore, our
protocolmay be applicable as amodel for chronic epilepsy studies
associated with alterations in adult neurogenesis and epileptic
seizures.
The protocol we describe here has been carefully standardized
and reproduced independently in three research centers. It
describes the local administration of KA into the mouse
hippocampus using stereotaxic injection and simultaneous
recording of EEG activity. Depending on the KA dose used,
this protocol induces different levels of epileptiform activity
and hippocampal alterations, such as granule cell dispersion
(GCD) and gliosis (Figure 1). Previous observations have
demonstrated that the protocol results in local regulation of
apoptosis, inflammation, chronic spontaneous seizures, as well
as strong alterations in resident neural stem cells, substantially
affecting their neurogenic potential. At the molecular level, these
alterations are reflected in significant changes in gene expression
(Schouten et al., 2015, 2016; Sierra et al., 2015).
Compared to other commonly used epilepsy models, in
particular the systemic administration of KA, this model offers
several advantages: (1) SE is initiated in the hippocampus,
whereas systemic convulsants may affect many brain areas at the
same time (including the cortex and limbic areas), complicating
the interpretation of results. (2) In addition, by modifying the
stereotaxic coordinates used for KA delivery, this protocolmay be
adapted to model epilepsy in other brain areas. (3) The protocol
describes the use of three doses of KA, which give the possibility
to induce neuronal hyperactivity at different intensities. (4)
In comparison with the systemic administration of KA, the
protocol allows for uni- or bi-lateral KA administration, sparing
the contralateral hippocampus as undamaged tissue control
in the short term (3 days post-injection, Figure 1). However,
the pathological changes induced by KA may extend to the
contralateral hippocampus at longer times post-injection. (5)
The protocol is dose-optimized in mice and thereby it can be
applied to numerous easily accessible transgenic mice lines of
interest. Regarding this last point, we recommend caution to
be applied while comparing different mouse strains, as KA-
sensitivity has been reported to differ between them, at least
when administered systemically (McLin and Steward, 2006;
Schauwecker, 2014). Finally, this model has the disadvantage of
potentially inducing local tissue damage around the needle track,
which we minimize by the use of glass pulled microcapillaries,
as originally described by Bouilleret et al. (1999), resulting in
minimal neuronal damage and local inflammation-induced glial
and neural stem cell reactivity (Sierra et al., 2015).
MATERIALS
- Kainic Acid Monohydrate (K0250, Sigma Aldrich)#
- Sterile Saline (Eurovet)
- Ethanol 70% (disinfectant)
- Mice (C57Bl6/J, Harlan, The Netherlands)
- Betadine (Premed healthcare B.V.)
#Kainic acid is a potent neurotoxin and thus has to be handled with care and
using proper personal protective equipment such as standard disposable latex
laboratory gloves, facial mask, and biosecurity goggles. Dispose any residual
solutions according to local regulations.
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FIGURE 1 | Kainic Acid dose-dependent effects on gliosis (A) and granule cell dispersion (B), 28 days post KA administration. Immunohistochemistry against
GFAP reveals clear dose-dependent gliosis effects, becoming apparent at 2.2 mM KA, which coincides with the presence of epileptic seizures. A Nissl staining to
assess granule cell dispersion only shows granule cell dispersion when administering 20 mM KA, while the seizure-inducing 2.2 mM shows no sign of dispersion.
Interestingly, for both gliosis and granule dispersion, the effects are limited to the ipsilateral hemisphere.
- Anesthetics and Analgesics: Isoflurane, Lidocaine, Ketamine
(Ketolar, Pfizer), xylazine (Sigma Aldrich), Buprenorphine
(Buprecare, Animalcare Ltd)
- Lubricant eye ointment (CEVA Netherlands)
- Dental Cement (Simplex Rapid, Kemdent)
- Surgical PVDF sutures (PRONOVA, Ethicon)∗
- Cotton swabs (Servoprax, Germany)
- Microlance injection needles, with bent tip (25G) (BD)
- Mineral Oil (M5904, Sigma Aldrich)
Equipment for Surgery and Injections
- Isoflurane anesthesia induction box
- Surgical Tools, including small surgical scalpel, scissors, and
forceps
- Watchmaker screwdriver set
- #5Dumont forceps (Fine Science Tools, Foster City, CA, USA)
- 1.5mm diameter Micro curette (Fine Science Tools)
- Electrical hair shaver
- Small animal digital stereotaxic apparatus (Kopf model 940
or Stoelting model 51730) equipped with a large probe holder
(Stoelting 51633) and a cannula holder (Stoelting 51636)
- Heating pad
- Dissecting Microscope (Olympus SZ61)
- Borosilicate glass capillaries (I.D. 0.53mm, O.D. 1.14mm;
3-000-203-G/X, SuedLabor, Germany)
- Nanoject II Auto-Nanoliter injector (Drummond Scientific
Company)
∗Braided silk sutures may induce an inflammatory response in the skin, thereby
increasing animal discomfort. Therefore, the use of PVDF sutures is advised
(Kakoei et al., 2010).
- Hand-held drill (Kopf model 1474-220) with matching drill
bits (drillhead 0.6mm/0.024 inch and 0.81mm/0.032 inch)
- Micropipette puller (model P-87, Sutter Instruments)
- Syringes (1.0mL) with 25 G needle
Equipment for Wireless Recording
- Wireless EEG recorders (Neurologger, TSE systems,
Germany)
- Neurologger Read Out Station (TSE systems, Germany)
- Wired recording electrodes consisting of 0.8 mm
shaft diameter gold plated screws, attached to 1.2
cm long electrode wire soldered to connector pins
matching the Neurologger (TSE Systems, Germany)
(Figure 2C).
- One wired reference/ground electrode that consists of two
separate wires attached to connector pins soldered to one
gold-plated screw.
Equipment for Wired Recording
- Nicolet video-EEG system (NicView 5.71, CareFusion, San
Diego, CA, USA) or Cereplex video- EEG system (Blackrock
Microsystems, Salt Lake City, UT, USA)
Six channel cable (363-441/6, PlasticsOne, Roanoke, VA,
USA)
- 5mm long (1mm stripped) platinum iridium, Teflon-
coated deep electrodes (E363/8; PlasticsOne). Teflon-coated
electrodes can be purchased 5mm long and later on cut at the
desired length with the help of a ruler and a razor blade (2mm
for the hippocampi, 1mm for the cortices). Do not forget to
strip the lastmm of teflon by cutting it away with a razor blade
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FIGURE 2 | Hardware needed for intrahippocampal administration of
KA and a guideline including crucial steps in the surgery procedure for
electrode implantation and EEG recordings. (A) The stereotaxic setup in
which the NanoJect is placed. (B) Close-up image of the injection capillary. (C)
Example of a recording electrode as used for the subdural wireless EEG
recordings. (D) Location of the burr holes in the skull as used for the wireless
EEG electrode implantation. (E) Placement of the subdural recording
electrodes in the burr holes. (F) Attaching the recording electrodes to the skull
with dental cement. (G) Covering the recording electrodes in dental cement
and attachment of the pin connector. (H) Example of a mouse carrying a
wireless recording device. (I) Example of a mouse in the wired EEG recording
setup.
(without damaging the electrode) and pulling from the tip of
the teflon with forceps.
- Plastic pedestal (MS363) and dust cap (363DC; Plastics One)
- Plastic pedestal holder (MH-636)
- Stainless steel mounting screws (00-96x1/16; Plastics One);
1.6mm shaft length, 2.16mm head diameter; 1.19mm shaft
diameter.
PROCEDURE
All animal procedures were performed following the European
directive 2010/63/UE and NIH guidelines and were approved
by the respective institutional Ethics Committees. Animal
procedures described herein are registered and approved by the
animal health and care committee, University of Amsterdam
(protocol #296).
Preparation of Surgery Area, Equipment,
and Materials
Before starting the surgical procedure make sure to thoroughly
disinfect the surgical table and any equipment that will be used.
70% ethanol suffices for surfaces, while tools preferably are
sterilized by autoclaving.
1. Prepare the KA solution to be used for injection. This
protocol uses three different doses of KA, each showing
differential EEG activity. The highest concentrations used (20
mM) induces status epilepticus and chronic seizures, while
the intermediate dose (2.22 mM; 1:9) induces mild non-
convulsive behavioral status, and the lowest dose (0.74 mM,
1:27) only results in enhanced epileptiform activity (Schouten
et al., 2015; Sierra et al., 2015).
2. Prepare KA stock solution by dissolving Kainic Acid
Monohydrate in sterile Saline. Prepare working stocks (10 uL)
and store at−20◦C.
3. Pull the glass capillaries to create injection needles. Injection
needles should be optimized in such a way that a very long
and thin shaft is obtained to reduce tissue damage (Figure 2B).
Fill one with mineral oil and attach it to the Nanoject injector.
Themineral oil is non-compressible and allows the pressure of
the injector to be evenly distributed, providing exact injection
volumes in the nanoliter range.
Anesthesia and Placement in the Stereotaxic
Apparatus
We recommend using isoflurane anesthesia as this allows for
a tight control of the anesthesia plane and the fastest recovery
after surgery. Alternatively, if an isoflurane setup is not at your
disposal it is also possible to use ketamine/xylazine (Sierra et al.,
2015), although ketamine is a NMDA channel blocker and
may potentially delay the initiation of seizures induced by KA.
Whichever the choice, the same anesthesia procedure should be
used for all animals within each experiment.
4. Weigh the animal before surgery to allow valid control of
post-surgical weight loss.
5. Place the animal in the isoflurane induction box (5%
isoflurane, 95% air, 250 CC/min) until the animal is fully
anesthesized. The animal should no longer be responsive to
nociceptive stimuli, such as pinching the toes with forceps.
Alternatively, inject with ketamine/xylazine (10/1 mg/kg,
intraperitoneal). As soon as the mouse is immobile, inject with
buprenorphine (1 mg/kg, subcutaneous), as the combination
of drugs leads to a deeper anesthesia. If the mouse is not fully
anesthetized within 10min, re-inject with ketamine alone (50–
100 ul of 100 mg/ml) to avoid a xylazine overdose that would
result in bradychardia and respiratory depression.
6. Proceed by shaving the fur of the skull, disinfect the skin with
betadine and place the animal in the stereotact. Make sure the
animal is placed horizontally and symmetrical to the earbars
by pulling from the base of its tail lightly before screwing the
earbars and nosebar tightly.
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Craniotomy
While performing the craniotomy and the subsequent steps of
this protocol make sure to monitor the general condition of the
animal. Make sure anesthesia is sufficient, but not too deep, to
allow a quick recovery from anesthesia. During these steps, adjust
the isoflurane percentage and/or flow when needed. As a general
guideline, 2% isoflurane at a flow of 250 CC/min should be used.
When using ketamine/xylazine it is usually not necessary to re-
anesthetize the animal because once deep anesthesia has been
reached it will last for 20–30min.
7. Start by making a midline incision from the frontal cranial
bones to the back of the parietal cranial bones using a small
blade scalpel. Push the skin aside so that the skull becomes
visible. To improve analgesia and reduce animal discomfort,
the local administration of lidocaine to the skull periost is
recommended by animal welfare officers in TheNetherlands.
Discuss the use of local lidocaine with your local animal
welfare officer. After 5 min, use small forceps and cotton
swabs to remove the periost and clean the skull surface.
8. Place the Nanoject Injector with the injection capillary in
the large probe holder of the stereotaxic fame (Figure 2A).
Identify the skull sutures and both bregma and lambda.
Make sure the head of the animal is leveled in the rostral-
caudal direction by measuring the Z coordinates of both
bregma and lambda and adjust the nosebar if needed. Follow
the same procedure for the horizontal positioning of the
animal by checking the Z coordinates at the midline and
two corresponding locations on the left and right side of
the midline. Horizontal positioning can only be adjusted, if
needed, by repositioning the animal in the apparatus and
readjusting the earbars.
9. When the animal is correctly positioned, proceed to identify
the coordinates of choice on the skull surface. In our
case, using P42 male C57BL/6 mice, we use the following
coordinates to target the DG: Anteroposterior (AP) −2.0,
mediolateral (ML)+1.5mm, dorsoventral (DV) −2.0mm
(Schouten et al., 2015), or AP −1.7, ML +1.6, DV −1.9
(Sierra et al., 2015) (both based on the Paxinos and Franklin
Brain Atlas). Using these coordinates KA infusion targets
the suprapyramidal blade of the dorsal DG. No differences
in the SE or epileptogenic activity of the hippocampus have
been found when comparing both protocols (Schouten et al.,
2015; Sierra et al., 2015). Besides the burr hole needed for
KA infusion, also drill holes for the recording electrodes are
necessary. For the wireless recording of the hippocampus,
drill one burr hole contralateral to the KA infusion site (AP
−2.0mm, ML−1.5mm), and another hole for the reference
electrode (AP+0.1, ML+0.1) (Figure 2D).
For the wired recordings of the cortex and hippocampus,
drill the holes at AP −0.1 mm, ML +1.6 mm (left cortex),
AP −0.1 mm, ML −1.6 mm (right cortex), and AP −1.8
mm, ML +1.6 mm (left hippocampus). Drill a hole for the
reference electrode in the frontral cortex at AP +0.1 mm,
ML +0.1 mm. Drill two additional holes for the mounting
screws at approximately AP +3.0, ML +6.0 and AP −8.0,
ML −0.5. It is important to place the mounting screws far
away from where the electrode pedestal will be positioned,
to avoid contact between the screws and the electrodes that
may produce interference with the electric signals recorded
from the brain.
10. Use the handheld drill to carefully drill holes in the skull
at the coordinates identified previously. Be careful while
applying pressure, as drilling through the bone will likely
cause damage to the brain parenchyma. Stop when you are
almost through the bone (blood vessels become clear). Use
a bent injection needle to further open the burr hole, and
remove any bone tissue with small forceps. Furthermore,
make sure to open up the dura, as this will interfere with the
smooth and straight insertion of the injection capillary.
Intrahippocampal Injection
11. Use the nanoject controller to fill the capillary with the KA
solution. Before injecting the KA, make sure to set the right
settings on the controller and push a few solution drops to
drain any possible air bubble at the end of the capillary.
We use the following nanoject settings: 4.6 nL/injection
at slow speed. Gently lower the capillary and identify the
Z coordinate for the brain surface. From there, lower the
capillary to -2.0 mm. Using the Nanoject controller, inject 50
nL (11 × 4.6 nL, every 10 s). Given the small total injection
volume, there is no need to wait with retracting the injection
capillary, as no backflow will occur.
Insertion of Recording Electrodes
From this point on, one has the option to implant electrodes of
choice. In this protocol we describe two different approaches,
both of which have been used in recent research publications. We
describe first a subdural neocortical wireless recording technique,
labeled A and previously used in Schouten et al. (2015) and an
intrahippocampal and intracortical wired recording, labeled B
and previously used in Sierra et al. (2015).
Subduralneocortical Wireless Recordings
11a. Using a watchmaker screwdriver, place the recording
electrodes in the burr holes created before. Place them
in such way that the tip of the electrode makes contact
with the brain surface (Figure 2E). It is important that
all electrodes are placed at the same depth, to ensure
comparable subdural recordings without creating tissue
damage. The exact depth and placement will depend on
the electrodes used, so electrode placement should be
optimized before the experiments. Gold-plated screws with
a diameter comparable, or slightly bigger, than the head of
the drill bit should be used, so that the screws fix themselves
on the bone.
12a. Once all electrodes are in place, completely dry the skull
surface and gently cover the electrodes with sufficient
dental cement to strengthen their hold on the skull. It
is important to let the cement dry completely before
proceeding to the next step (Figure 2F).
13a. Connect the electrodes to the pin connector and gently
wind up the electrode wire in such a way that they
take up as little place as possible, and the pin connector
is positioned horizontally and pointing backwards. The
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position of the pin connector is very important, as the
Neurologger will be attached later, and weight distribution
of the logger is essential to minimize animal discomfort
and free movement. When the wire and pin connector
are in position, fix the structure with dental cement
(Figure 2G). This will not only strengthen the connection
to the skull, but will also protect the electrodes from
damage.
Intrahippocampal and Intracortical Wired Recordings
11b. Screw the stainless steel mounting screws in their holes
with the watchmaker screwdriver by holding them from
their head with the Dummont forceps.
12b. Place the six electrodes in the electrode pedestal with the
help of the Drummond forceps in their correct position.
Use 2mm long electrodes for the hippocampi, 1mm
electrodes for the cortices and the reference electrode,
and a bent 5mm electrode for the ground electrode
that will be positioned over the cervical paraspinous
area. Attach the plastic pedestal to its holder, and this
piece to the cannula holder of the stereotaxic apparatus.
Make sure the pedestal holder is correctly aligned to the
vertical axis of the stereotaxic frame. Draw a vertical line
over the midline of the pedestal holder to facilitate the
visual alignment.
13b. Lower the pedestal holder so that the five deep electrodes
are positioned right above their drill holes. Make sure
the five are on their correct position pushing them
lightly with the help of the Drummond forceps. Lower
the pedestal to its final position contacting the skull.
Apply dental cement with the micro curette around the
pedestal and screws, creating a small mount covering the
skull exposed right up to the skin borders. Make sure
the dental cement does not cover the skin to prevent the
pedestal to become detached over time. While creating
the mount, keep the dental cement to be applied in a
semiliquid state by adding more solvent as necessary.
Thick dental cement will produce a crumbly mount,
while liquid dental cement will be too slippery to be
applied in the right position. Cover the pedestal with the
plastic pedestal cap.
14a/b. Let the dental cement dry out completely before
removing the animal from the stereotaxic apparatus.
Keep the animal warm using an electric heat pad until
it is awake and ambulant (5 min in A, 30 min–1 h in B).
EEG Recording and Data Collection
Wireless Recording
15a. Attach the pin connector on the mouse skull to the
Neurologger (Figure 2H). The wireless Neurologger
provides 72 h of continuous recording at a sampling rate of
500 Hz. Once every 3 days the batteries have to be replaced.
While replacing the batteries, collect data from the recorder
using the Neurologger ReadOut station. Neurologger
software provides plugins to convert data into Matlab
compatible files for analysis.
Wired Recordings
15b. Immobilize the mouse down to a flat surface by holding its
back with the hand palm and both sides of the pedestal with
the index and thumb. If necessary, a light anesthesia can be
administered (2% isofluorane in an induction chamber for
30 s). Remove the pedestal cap and attach the pedestal to
the six channel cable connected to the Nicolet or Cereplex
recorders. The mouse can be recorded at different sampling
rates in 4 h sessions in a cage without access to food or
water to prevent the cable from tangling, for up to 50 days
(Figure 2I).
Potential Pitfalls and Troubleshooting
The protocol described here makes use of general stereotaxic
surgery procedures and therefore most of its potential pitfalls
have been described elsewhere (Cetin et al., 2007). However,
several specific points have to be closely monitored in order to
perform the procedure correctly.
1. The choice of anesthetics is crucial for interpreting the
obtained results. As mentioned above the use of Isoflurane
anesthesia is recommended, as isoflurane does not affect ion-
channel function, and therefore does not interfere with seizure
induction. However, an isoflurane setup will not always be
available, which may influence the choice of anesthetics. As
we have shown before, Ketamine/Xylazine anesthesia provides
a widely used alternative (Sierra et al., 2015; Abiega et al.,
2016). However, potential differences in status epilepticus
delay and/or intensity may arise when comparing isofluorane
and ketamine anesthetized mice.
2. The placement of the animal in the stereotaxic apparatus is
crucial for proper localization of the injection capillary. If the
animal is not correctly placed, the injection coordinates will
not correspond to the area of interest. It is crucial to always
check the rostral-caudal and medial-lateral alignment using
the dorsal-ventral stereotaxic coordinates.
3. Though the anesthesia procedures described in this protocol
have been thoroughly standardized, animal well-being must
always be monitored very closely. Anesthetics dosages
described here provide a general guideline, though differences
in inter-animal sensitivity to anesthesia occur. Therefore,
always monitor breathing and heart rate of the animal
throughout the procedure, and adjust anesthetics if necessary.
4. Since the injection volume is very small and the injection
capillary diameter is very narrow it is important to closely
monitor the tip of the capillary prior to and during the
procedure. First, because of the small diameter of the glass
pipette, capillary action might result in displacement of
the KA solution in the capillary tip by blood or other
liquids encountered on the brain surface. This can be easily
monitored under the microscope while lowering the injection
capillary onto the brain surface. If capillary action occurs
always retract the capillary and reload the KA solution.
Secondly, the glass pipette can easily clog because of its small
diameter. Before inserting the capillary always check whether
clogging occurred by performing a test-injection outside of the
skull.
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5. Placement of the electrodes is crucial for correct
electrophysiological recordings. In the wired approach
described here electrodes are placed in the brain, and
therefore the same pitfalls apply as for the KA injection itself.
For the wireless, neocortical approach described, placement
of the electrodes has to be optimized, as the electrode
screws have to be placed touching the brain surface. Since
these procedures cannot be visually monitored, electrode
placement has to be checked post-mortem. In our wireless
setup and using the gold-plated screws described here, two
full turns with a screwdriver delivered optimal results. When
using other screws, mice of other age, or other rodent species
in which the skull thickness might differ, this procedure must
be re-optimized.
6. Because the recording electrodes in the wireless approach
are placed on top of the brain, it is crucial that they
are firmly fixed to the skull. Due to the weight of the
recording system, electrodes may detach, which cannot be
repaired without removing the whole electrode/dental cement
assembly. Therefore, make sure to create drill holes slightly
smaller than the diameter of the recording electrodes, and air-
dry the skull carefully before fixing the electrodes with dental
cement.
7. Since we use a multi-channel recording approach, it is critical
to always connect the electrodes in the same order, and
to assign each electrode to the same channel throughout
the entire procedure. In this way, the recordings from each
channel will always be allocated to the same electrode,
facilitating inter-experiment data comparison.
8. Electrostatic noise might interfere with the EEG recordings,
depending on the setup and its position in the room
(Figures 3A,B). Using the wireless approach, electrostatic
noise is not a major concern, as all data is collected in a
closed system within the recorder. The wireless recorder is
built in such a way that all electrodes are grounded, when
placed properly. To avoid electrostatic noise, the individual
electrodes must not touch each other. For the wired EEG
approach electrostatic noise may be a bigger concern, though
this fully depends on the surroundings in which the animals
are recorded. If electrostatic noise occurs, a Faraday cage
proved to be sufficient to solve the problem in our case
(Figure 3C).
ANTICIPATED RESULTS AND DISCUSSION
Intrahippocampal Administration of KA as
an Alternative to Systemic Convulsants
This protocol describes the use of intrahippocampal KA, in
multiple doses, to elicit epileptiform activity and SE. The highest
dose (50 nL, 20 mM) triggers SE similar to systemic KA
administration models, however the origin of the seizures, and
their behavioral manifestations are different. Locally delivered
KA may act on KA and AMPA receptors located both pre-
and post-synaptically in pyramidal and granule cells, regulating
neurotransmission (Vincent and Mulle, 2009), In contrast,
systemic convulsants may act on the whole brain and target
different circuits in brain regions enriched in KA receptors,
including the cerebral cortex or the amygdala (Vincent and
Mulle, 2009). In our intrahippocampal administration model,
we have observed largely the same effects (seizure severity,
epileptiform activity monitored by EEG, gliosis, effects on
the hippocampal neural stem cells) independently of small
differences in the coordinates used to inject KA into the
DG, supporting the idea that a common circuit is activated.
As a result, the high dose of KA is an excellent model of
mTLE, as it resembles some of its pathological hallmarks,
such as changes in gene expression, induction of reactive
gliosis, granule cell dispersion, apoptosis, inflammation, the
occurrence of chronic recurrent seizures, and deregulation of
the neurogenic process (Schouten et al., 2015; Sierra et al.,
2015).
Systemic delivery usually requires multiple injections of the
chemoconvulsant until the point in behavioral seizures quantified
by the Racine scale can be observed (McLin and Steward,
2006). Thereby, the number of injections needed varies largely
per animal, making the KA dose a factor virtually impossible
to standardize under these circumstances and resulting in
experimental variability that may be associated with result
irreproducibility (Hellier et al., 1998; McLin and Steward, 2006).
Using the protocol described herein, the dose of KA administered
locally can be tightly controlled, allowing the characterization of
dose and seizure intensity-dependent effects.
Low-Grade Epileptiform Activity Induction
Whereas other classical models strive to elicit full-blown SE
and subsequent chronic recurrent seizures, our model also
provides the possibility to induce lower grade epileptiform
activity, depending on the KA dose locally delivered, which
has its own effects on the hippocampal niche (Sierra et al.,
2015). Given the large inter-animal susceptibility when KA is
administered systemically, it is virtually impossible to accurately
standardize non-SE inducing KA doses, which may generate
unwanted experimental variability. The intrahippocampal KA
administration described here offers the opportunity to treat
multiple animals with the same convulsive or non-convulsive
dose of KA, as the local KA dosage can be tightly regulated,
allowing the detailed study of the effect of non-seizure-inducing
KA-induced neuronal hyperactivity in the hippocampus and the
effects of varying seizure intensities as well (Schouten et al., 2015;
Sierra et al., 2015).
Between and within Strain Susceptibility
Though not new, the intrahippocampal KA model has not
been extensively used in mice. However, multiple studies have
already made use of this model in rats, where it has been
validated as a good epilepsy model on multiple levels, such as
SE induction, latency, rise of recurrent chronic seizures, and
pathological hallmarks (Cavalheiro et al., 1982, 1983; French
et al., 1982; Cook and Crutcher, 1986; Davenport et al., 1990;
Leite et al., 1996; Rattka et al., 2013). Keeping in mind the strain-
specific KA vulnerability and within-strain individual differences
in KA vulnerability in systemically treated mice, systemic
administration of KA presents several limitations as epilepsy
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FIGURE 3 | Example traces of noise-free and noisy EEG recordings and Faraday cage design. (A) Example trace of a noise-free recording showing small
deviations from baseline activity. (B) Example trace of a noisy recording showing significant deviations from baseline activity to an extent that may overlap with
changes from baseline in the noise-free recording. (C) Example of a Faraday cage used to prevent noisy EEG recordings.
model in mice. Unfortunately, because of its limited use, no data
is yet available on strain differences in KA vulnerability using
intrahippocampal injections, as we describe here. Thus, far, only
mice on a C57Bl6 background have been used in an experimental
setup (Schouten et al., 2015; Sierra et al., 2015). However, our
previous observations suggest that the within-strain variability
is significantly reduced using local administration protocols
(Schouten et al., 2015; Sierra et al., 2015). Together with the
numerous possibilities that transgenic mouse lines offer, the use
of intrahippocampal KA provides new opportunities for the
preclinical epilepsy field. We propose that the intrahippocampal
KAmodel should be considered a suitable and easy to standardize
epilepsy model used for mice, which will improve inter-center
reproducibility and provide a complementing method for the
systemic application of KA.
Local Damage
One factor to consider when using the intrahippocampal KA
model is the surgical procedure needed to induce SE. This
is especially the case for experiments in which no recording
electrodes are placed, since these would not need any surgical
procedure when KA would be administered systemically.
Though only a short procedure, anesthetics may influence
the effects of KA and there is always a risk of damage to the
brain. Therefore, it is important to carefully select the anesthetic
of choice, and optimize the surgery protocol. In our hands, no
clear local damage can be found in the hippocampus besides
the presence of the needle tract due to the stereotaxic surgery
procedure. We have not found any indications of inflammatory
markers surrounding the needle tract, confirming that the
sterile invasive procedure may not result in significant local
inflammatory response, which could be a confounding factor in
epilepsy models (Sierra et al., 2015).
In conclusion, the protocol for intrahippocampal
administration of KA described here offers the advantage
of allowing a controlled release of the convulsant dose of
choice, in the specific location of interest, and in a variety
of transgenic mouse models, while limiting the local damage
induced in the injection site. Nonetheless, it should be noted
that this model has not been as thoroughly characterized as the
systemic models, in particular regarding the latent and chronic
periods (duration and frequency of seizures, etc), and thus
further characterization is needed in this respect. Overall, the
intrahippocampal administration of KA offers a great potential
to understand the underlying pathophysiology of epilepsy and
mTLE.
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